GSG. M. Sharafutdinova

G. M. Sharafutdinova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


G. M. Sharafutdinova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Trends in the overall incidence of multiple sclerosis among the adult population of the Russian Federation in 2013—2024

    by G.M. Sharafutdinova, I.M. Son, D.I. Marapov

    With the growing incidence of multiple sclerosis in the Russian Federation, the burden on the healthcare system is increasing. Studying the trends in multiple sclerosis (MS) among the adult population, which is the most active, is crucial for creating a scientifically sound system for providing medical care to MS patients. Objective. The purpose of this study is to examine the overall incidence of multiple sclerosis among the adult population of the Russian Federation from 2013 to 2024. Materials and methods. The analysis of the overall incidence of MS in the adult population of the Russian Federation (RF) and its federal districts for the period from 2013 to 2024 was conducted. Statistical analysis was carried out using the StatTech v. 4.12.2 program (developed by StatTech LLC, Russia). The analysis of time series was performed with the calculation of absolute and relative growth (decline) indicators, the alignment of the time series using the methods of interval enlargement and moving average. Results. When analyzing the dynamics of the overall incidence of multiple sclerosis in the Russian Federation, there was an almost steady increase from 53.6 to 86.5 per 100.000 adult population in all federal districts over the study period. The overall increase in the overall incidence of MS among adults over a 12-year period was 32.9 cases, or +61.4%. The highest growth rate for 2013—2024 was observed in the North-Western Federal District, with a growth rate of 71.8 per 100.000 population, corresponding to a growth rate of +111.3%. The lowest growth rate was observed in the North-Caucasian Federal District, with a growth rate of +23.0%. Conclusion. The increase in the absolute number of MS patients registered in medical institutions, who receive expensive treatment and a range of social support measures, places a significant burden on healthcare. In this regard, research aimed at studying the medical care system in the regions of the Russian Federation, developing primary and secondary prevention measures, and timely diagnosis and treatment of multiple sclerosis becomes particularly relevant.

  • Differential diagnosis of dizziness and symptomatic therapy

    by F. A. Khabirov, G. M. Sharafutdinova, N. N. Babicheva, A. R. Khaibullina, T. I. Khaibullin, O. S. Kochergina

    Dizziness is one of the most common reasons for seeking medical attention from specialists in various fields. However, despite its apparent clarity, patients describe a wide range of sensations under this term: from loss of balance and uncertainty when moving to swaying, lightheadedness, pre-syncope, “heaviness in the head”, and coordination problems. Patients often struggle to clearly articulate their complaints and offer several different definitions of their condition. Specifying complaints can be difficult, which complicates diagnosis and determining the cause of dizziness. Therefore, modern practice uses a diagnostic algorithm that includes assessing the nature of vestibular syndrome (acute, intermittent, or persistent), identifying triggering factors, analyzing associated symptoms, performing a physical examination, and, if necessary, additional diagnostic methods. A clinical case study of a patient with multiple sclerosis who initially presented with complaints of dizziness illustrates the complexity of diagnosing this condition. In the treatment of dizziness, the primary goal is rapid and effective symptom relief. Given the frequent presence of comorbidities requiring the simultaneous use of multiple medications, combination medications are preferred. One such drug is the fixed-dose combination of dimenhydrinate 40 mg and cinnarizine 20 mg (Arlevert). Low doses of dimenhydrinate and cinnarizine enhance each other’s effects when used together, with minimal adverse effects. Due to the different mechanisms and locations of action of the components (peripheral action of cinnarizine and central action of dimenhydrinate), Arlevert is the only anti-dizzy medication with synergistic action in both peripheral and central areas.

  • FACTORS OF OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE SCLEROSIS

    by G.M. Sharafutdinova, D.I. Marapov

    Currently, the incidence of multiple sclerosis is steadily increasing. Unfortunately, the disease mainly affects the working-age population and increases the risk of premature mortality. This study is devoted to the assessment of the overall survival of patients with multiple sclerosis (MS), taking into account the influence of various factors. An observational retrospective study was conducted based on data from the regional registry of MS patients of the Republican Clinical Diagnostic Center for Demyelinating Diseases of the Ministry of Health of the Republic of Tatarstan. The study group consisted of 2,673 patients registered for MS from 2007 to 2022. There were 204 deaths among them (7.6% of the total number of patients studied). The overall survival rate of MS patients is characterized by a smooth gradual decrease. The five–year survival rate was 98.0% (95% CI: 97.3 – 98.5%), the ten-year survival rate was 91.9% (95% CI: 90.5 – 93.2%). A statistically significant effect on the risks of death in MS patients was found for the form of the underlying disease, the fact that PITRS was prescribed, the age at the time of inclusion in the register, and the initial assessment of the degree of neurological disorders on the EDSS scale (Expanded Disability Status Scale). Determining the risk factors for death in MS using survival analysis is an important condition for understanding the prognosis of the disease at an early stage of patient follow–up - when making a diagnosis and inclusion in the regional nosological registry. Taking into account the identified factors will optimize treatment and rehabilitation tactics in the management of MS patients, reduce the risk of death, and properly allocate the resources of a medical organization depending on the established risk of an adverse outcome.


  • DISABILITY AND LETHALITY RATES IN PATIENTS WITH MULTIPLE SCLEROSIS IN THE REPUBLIC OF TATARSTAN

    by G.M. Sharafutdinova, D.I. Marapov, I.R. Iskandarov

    A significant proportion of the working-age population suffers from multiple sclerosis, and the incidence of multiple sclerosis (MS) is increasing every year, leading to permanent limitations in daily life and a decrease in life expectancy, including in the Republic of Tatarstan (RT). The purpose of this study is to assess the rates of disability and mortality among patients with multiple sclerosis over a five-year period since their registration in the Republic of Tatarstan, broken down by municipal districts. This study was based on data from patients with multiple sclerosis between 2007 and 2018. A total of 1,848 patients were included in the study, including 567 men (30.7%) and 1,281 women (69.3%). The follow-up period was at least 5 years, provided there were no fatalities. The number of MS patients who died within 5 years of inclusion in the register was 41 (2.2%), and the number of patients who were observed alive for at least 5 years of inclusion in the register was 1,807 (97.8%). The five-year mortality rate for MS patients registered in the regional register ranged from 0% to 25%. It should be noted that 26 municipalities in the Republic of Tatarstan had zero values for this indicator. Maximum values of more than 10% lethality were observed in 6 municipalities. According to the regional register, the number of patients who became disabled was 634 (34.3%), while the number of patients who remained disabled for at least 5 years since inclusion in the register was 1214 (65.7%). The share of the I disability group was the lowest, at 20.0% (127 people), the share of the II group was 37.7% (239 people), and the share of the III group was 42.3% (268 people). The disability rate of patients with MS in the municipalities ranged from 0% to 88.9%. The lowest disability rates of 0.0% to 27.2% were observed in 11 municipalities, including Kazan. More than 50.0% of disabled people were observed in 16 municipalities. High rates of disability, with a low proportion of disabled people in Group I and a low five-year mortality rate, can be considered a sign of sufficient and timely provision of medical and social protection measures for MS patients for the period 2007-2018, which have a positive impact on preserving life and health and increasing the period of no critical changes in the level of disability.

  • Features of the clinical course of multiple sclerosis as a factor in persistent disability

    by G.M. Sharafutdinova, F.A. Khabirov, D.I. Marapov, T.I. Khaybullin

    Objective. To study the effect of clinical factors on the disability of multiple sclerosis (MS) patients based on the data from the Republic of Tatarstan. Materials and methods. The study was based on the patient data from the regional register of patients with MS of the Republic of Tatarstan maintained at the Republican Clinical Diagnostic Center for Demyelinating Diseases of the Ministry of Health of the Republic of Tatarstan. Of the 2.673 patients with a confirmed MS diagnosis, 749 (28.0%) had disabilities, including 299 (11.2%) with disability group III, 267 (10.0%) with disability group II, and 183 (6.8%) with disability group I. Results. It has been established that the disability of MS patients depends on various clinical factors, such as the nosological form of MS, onset variants, values of the Extended Disability Rating Scale (EDSS) at the time of inclusion in the register, and the availability of treatment with multiple sclerosis disease-modifying drugs (MSDMD). Patients with secondary-progressive or primary-progressive MS, with slight symptoms at the onset of the disease, not receiving MSDMD treatment, and with baseline EDSS scores over 3 at the time of inclusion in the register have a higher risk of disability. Conclusion. The obtained results demonstrate the importance of timely access to medical care and specific treatment for patients with MS to preserve their working capacity and active life and significantly delay severe health disorders. The persistent nature of disability in patients with MS and the high rate of disability in patients (more than ¼ of those with MS) indicates the relevance of further study of the factors influencing the occurrence and development of disability in this group of patients.

  • DISABILITY FACTORS IN MULTIPLE SCLEROSIS PATIENTS

    by Sharafutdinova G.M., Marapov D.I., Sabirova E.R., Khaibulli T.I.

    This study is devoted to the study of the level of disability and factors influencing the disability of patients with multiple sclerosis (MS). The dependence of the incidence of disability in MS patients on various socio-hygienic and biological factors was assessed. The results of a retrospective study of 2,893 patients with multiple sclerosis showed that there were 749 people with disabilities, their share in the overall sample was 28.0%. In the structure of patients with MS with permanent disability, the largest proportion were disabled people of group III (39.9%, in the total structure of MS patients – 11.2%), the proportion of disabled people of group II was 35.6% (in the total structure of MS patients – 10.0%), group I – 24.4% (in the total structure of MS patients – 6.8%). Men differed from women in a higher proportion of disabled people in groups I-II, the figures were 19.7% and 15.5%, respectively. The disabled differed significantly later in age at the time of inclusion in the register, the median was 39 years. The age at the time of inclusion in the register among non-invalids was 7 years earlier – the median was 32 years. The rate of disability among MS patients was significantly higher among the rural population (35.2%), while among the urban population the proportion of disabled people was only 22.4% (p<0.001). The analysis revealed statistically significant differences in the distribution of the studied disability groups depending on education (p<0.001). The proportion of patients with disability groups I-II prevailed in secondary education (57.5%), and the proportion of patients without disabilities was higher in secondary specialized or higher education (51.8 and 36.0%). It is concluded that the disability of patients depends on various socio-hygienic and biological factors. The disabling nature of the disease indicates the need for further study of the factors influencing disability and the need to improve the system of medical care for patients with multiple sclerosis.

  • Main Scientific Directions of Oncology Development in the Republic of Tatarstan

    by Rustem Sh. Hasanov, Guzel M. Akhmedova, Luisa G. Karpenko, Ilgiz G. Gataullin

    The article is devoted to the main directions of oncology development in the Republic of Tatarstan. The results of comprehensive scientific research of the Kazan Scientific Oncology School are presented, the main scientific directions of the development of oncology in the Republic of Tatarstan are highlighted. Currently, the Oncological Service of the Republic of Tatarstan unites the Oncological Dispensary with branches, the Departments of Oncology, Radiology and Palliative Medicine, Obstetrics and Gynecology, Urology, Radiation Diagnostics of KSMA, the Department of Oncology, Radiation Diagnostics and Radiation Therapy of KSMU and other departments. Several important stages of the formation of the Kazan Scientific Oncological School are noted. The history of development is inextricably linked with the formation of the Department of Oncology at Kazan State Medical Academy. The main measures to reduce mortality from cancer are presented. The main tasks of the oncological service of the Republic of Tatarstan are described. Scientifically based complexes of measures for the rehabilitation of cancer patients have been implemented. Scientific knowledge has been translated into healthcare. Approaches to the organization of oncological services based on modern scientific achievements, developed methods of rehabilitation and palliative care, the implementation of these approaches into clinical practice contribute to improving the effectiveness of providing medical care to cancer patients, achieving the set targets.